Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Bacterial toxin may fuel alcohol cravings in heavy drinkers

NCT ID NCT04527185

First seen Nov 03, 2025 · Last updated Jun 20, 2026 · Updated 37 times

Summary

This study tested whether a bacterial toxin called endotoxin can increase alcohol consumption in people with alcohol use disorder. 27 participants received either endotoxin or a placebo, and their alcohol intake was measured during a 2-hour session. The goal was to gather early data on how inflammation might affect drinking behavior.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Yale School of Medicine

    New Haven, Connecticut, 06519, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Endotoxin (lipopolysaccharide)

What this could lead to

If this study shows a link, it could point toward new ways to understand and treat alcohol use disorder by targeting inflammation.

What could go wrong

This is a small, early-phase pilot study with only 27 people. The results may not apply to everyone with alcohol use disorder, and the findings are preliminary.

Conditions

The condition(s) this trial relates to.

alcohol abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.